Site Selection of Short Peripheral Venous Catheters (SPECIAL)

January 7, 2019 updated by: Chuanjie Wu, The First Affiliated Hospital of Zhengzhou University

Site Selection of Peripheral Venous Access Via Short Peripheral Catheters in Adult Patients (SPECIAL Trial)

Up to 90% of catheters fail before therapy is complete. Improved dwell time of intravenous catheters for even small increments of time would further reduce the number of insertions, staff workloads, and costs. In this study, the investigators investigated whether short peripheral venous catheter site of insertion influence the dwell time.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1517

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Anhui
      • Suzhou, Anhui, China
        • Suzhou Municipal Hospital
    • Beijing
      • Beijing, Beijing, China
        • Xuanwu Hospital Captial Medical University
    • Guizhou
      • Guiyang, Guizhou, China
        • Guizhou Provincial People's Hospital
    • Henan
      • Zhengzhou, Henan, China, 450000
        • The First Affiliated hospital of Zhengzhou University
      • Zhengzhou, Henan, China
        • The fifth Affiliated Hospital of Zhengzhou University
    • Hunan
      • Xiangtan, Hunan, China
        • Xiangtan Central Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >18 years
  • Expected duration of infusion therapy by short peripheral intravenous catheters >7 days
  • Give written informed consent

Exclusion Criteria:

  • The peripheral venous catheter was inserted in emergency room or in emergency circumstances
  • Bloodstream infection
  • Had a peripheral venous catheter already in situ at the baseline
  • Altered mental state

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Dorsum of hand group
short peripheral venous catheter place in the dorsum of the hand
Device: short peripheral venous catheter
short peripheral venous catheter for infusion therapy in adult patients
Experimental: Forearm group
short peripheral venous catheter place in the forearm
Device: short peripheral venous catheter
short peripheral venous catheter for infusion therapy in adult patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Indwelling time
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Phlebitis
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks
Occlusion of the catheter
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks
Infiltration
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks
Accidental catheter removal
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks
Local venous infection
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks
Catheter-related bloodstream infection
Time Frame: from the cannulae insertion until its removal, usually within 2 weeks
from the cannulae insertion until its removal, usually within 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The First Affiliated Hospital of Zhengzhou University

Investigators

  • Study Chair: Chuanjie Wu, MD, The First Affiliated hospital of Zhengzhou University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2017

Primary Completion (Actual)

December 26, 2018

Study Completion (Actual)

January 6, 2019

Study Registration Dates

First Submitted

September 17, 2017

First Submitted That Met QC Criteria

September 20, 2017

First Posted (Actual)

September 25, 2017

Study Record Updates

Last Update Posted (Actual)

January 8, 2019

Last Update Submitted That Met QC Criteria

January 7, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • FAHZU-2017-016

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Short Peripheral Venous Catheter

Clinical Trials on short peripheral venous catheter

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe